<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02287857</url>
  </required_header>
  <id_info>
    <org_study_id>CTTQ-TDF-V3.0</org_study_id>
    <nct_id>NCT02287857</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety of Domestic Tenofovir Tablets in Chinese Patients With Chronic Hepatitis B</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the safety and efficacy of Domestic Tenofovir
      Disoproxil Fumarate Tablets in Chinese patients with hepatitis B ,compared with Tenofovir
      Disoproxil Fumarate Tablets of Gilead.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2014</start_date>
  <completion_date type="Anticipated">October 2019</completion_date>
  <primary_completion_date type="Anticipated">October 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Compared with baseline, decline of serum HBV-DNA in the value</measure>
    <time_frame>1 month</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">260</enrollment>
  <condition>Chronic Hepatitis B</condition>
  <arm_group>
    <arm_group_label>Domestic Tenofovir Disoproxil Fumarate Tablets</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Tenofovir Disoproxil Fumarate Tablets of Gilead</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Domestic Tenofovir Disoproxil Fumarate Tablets</intervention_name>
    <description>1 Domestic Tenofovir Disoproxil Fumarate Tablets and 1 blank Tenofovir Disoproxil Fumarate Tablets of Gilead</description>
    <arm_group_label>Domestic Tenofovir Disoproxil Fumarate Tablets</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Tenofovir Disoproxil Fumarate Tablets of Gilead</intervention_name>
    <description>1 blank Domestic Tenofovir Disoproxil Fumarate Tablets and 1Tenofovir Disoproxil Fumarate Tablets of Gilead</description>
    <arm_group_label>Tenofovir Disoproxil Fumarate Tablets of Gilead</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The initial treatment of subjects diagnosed of HBeAg positive or negative chronic
             hepatitis B

          -  Aged 18 to 65 years old，male or female

          -  Patients with previously HBsAg-positive lasted for 6months at least：HBeAg-positive
             subjects, HBV-DNA&gt; 105copies/ml； HBeAg-negative subjects, HBV-DNA&gt; 104copies/ml.

          -  2 times the upper normal limit (2 × ULN) ≤ alanine aminotransferase (ALT) ≤ 10 × ULN.

          -  Total serum bilirubin (TBIL) ≤ 2.5 × ULN.

          -  Prothrombin activity (PTA) ≥ 60% or prothrombin time prolonged than normal ≤ 3
             seconds).

          -  WBC ≥ 3.5 × 109 / L, PLT ≥ 80 × 109 / L, serum albumin (ALB)≥ 35 g / L.

          -  Creatinine (Cr) ≤ 1× ULN，serum phosphate was normal.

          -  Patients signed an informed consent form and compliance was good.

        Exclusion Criteria:

          -  Patients were infected with other viruses as HAV, HCV, HEV, HIV etc.

          -  Patients with cirrhosis or liver cancer.

          -  Pregnant woman, lactating women .

          -  Patients with severe heart, kidney, endocrine hematopoietic system and
             neuropsychiatric diseases.

          -  Patients with metabolic or autoimmune diseases such as systemic lupus erythematosus.

          -  Patients allergic for study drug.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yan yan Yu, doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Peking University First Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hao Wang, doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Peking University People's Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jun Chen, doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Beijing Ditan Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Xin yue Chen, doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Beijing You An Hospital, Capital Medical University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Wen hong Zhang, doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Huashan Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Qing Xie, doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ruijin Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Shan ming Wu, doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Shanghai Public Health Clinical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hong Tang, doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>West China Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Qing Mao, doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>First Affiliated Hospital, Third Military Medical University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Zhi liang Gao, doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Third Affiliated Hospital of Sun Yat-sen</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ji fang Shen, doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>First Affiliated Hospital of Zhejiang University School of Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jun Li, doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>The First Affiliated Hospital with Nanjing Medical University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Wei Zhao, doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Second Hospital of Nanjing</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jia Shang, doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Henan Provincial Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Zu jiang Yu, doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>The First Affiliated Hospital of Zhengzhou University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yan yan Yu, doctor</last_name>
    <phone>13901194223</phone>
    <email>yyy@bjnu.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Beijing Ditan Hospital Capital Medical University</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100015</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xiao hua Hao, doctor</last_name>
      <phone>13466590802</phone>
      <email>xiaohualuck@sina.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Peking University First Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100034</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Li qin Yu, doctor</last_name>
      <phone>010-66119025</phone>
      <email>jgbgs090101@126.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Peking University People's Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100044</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hao Wang, doctor</last_name>
      <phone>010-88325988</phone>
      <email>jgbgs090101@126.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Beijing You An Hospital, Capital Medical University</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100069</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mei xia Wang, doctor</last_name>
      <phone>010-83997322</phone>
      <email>youangcp@163.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>First Affiliated Hospital, Third Military Medical University</name>
      <address>
        <city>Chongqing</city>
        <state>Chongqing</state>
        <zip>400039</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yong chuan Chen, doctor</last_name>
      <phone>13883405537</phone>
      <email>zwmcyc@163.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Third Affiliated Hospital of Sun Yat-sen</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510630</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Qian Huang, doctor</last_name>
      <phone>02085253153</phone>
      <email>sankyk@163.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Henan Provincial People's Hospital</name>
      <address>
        <city>Zhengzhou</city>
        <state>Henan</state>
        <zip>450003</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xiu Jin, doctor</last_name>
      <phone>13526660319</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>First Affiliated Hospital of Zhengzhou University</name>
      <address>
        <city>Zhengzhou</city>
        <state>Henan</state>
        <zip>450052</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Juan Li, doctor</last_name>
      <phone>13526506270</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Second Hospital of Nanjing</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210003</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yu Pan, doctor</last_name>
      <phone>13814099474</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>First Affiliated Hospital of Nanjing Medical University</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xu Huang, doctor</last_name>
      <phone>02568136360</phone>
      <email>jsphkj@163.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ruijin Hospital Shanghai Jiaotong University School of Medicine</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200025</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yi feng Wang, doctor</last_name>
      <phone>02154661789</phone>
      <email>ruijin_gcp@126.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Huashan Hospital, Fudan University</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200040</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fei Dong, doctor</last_name>
      <phone>02152888041</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Shanghai Public Health Clinical Center</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>201508</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Na Li, doctor</last_name>
      <phone>18916082023</phone>
      <email>lina40125@shaphc.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>West China Hospital of Sichuan University</name>
      <address>
        <city>Chengdou</city>
        <state>Sichuan</state>
        <zip>610041</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Juan Liao, doctor</last_name>
      <phone>15828323384</phone>
      <email>hxcrgcp@163.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>First Affiliated Hospital of Zhejiang University School of Medicine</name>
      <address>
        <city>Hangzhou</city>
        <state>Zhejiang</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Li hua Wu, doctor</last_name>
      <phone>13819195192</phone>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>October 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 30, 2014</study_first_submitted>
  <study_first_submitted_qc>November 6, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 11, 2014</study_first_posted>
  <last_update_submitted>November 6, 2014</last_update_submitted>
  <last_update_submitted_qc>November 6, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 11, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hepatitis</mesh_term>
    <mesh_term>Hepatitis, Chronic</mesh_term>
    <mesh_term>Hepatitis B</mesh_term>
    <mesh_term>Hepatitis B, Chronic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tenofovir</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

